Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates | Zendy

Renru Han | Zendy; Yang Xue-lin | Zendy; Yang Yang | Zendy; Yan Guo | Zendy; Dandan Yin | Zendy; Li Ding | Zendy; Shi Wu | Zendy; Demei Zhu | Zendy; Fupin Hu | Zendy

Open Access

Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates

Author(s) -

Renru Han,

Yang Xue-lin,

Yang Yang,

Yan Guo,

Dandan Yin,

Li Ding,

Shi Wu,

Demei Zhu,

Fupin Hu

Publication year - 2022

Publication title -

microbiology spectrum

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.502

H-Index - 51

ISSN - 2165-0497

DOI - 10.1128/spectrum.01092-21

Subject(s) - etest , broth microdilution , klebsiella pneumoniae , ceftazidime/avibactam , microbiology and biotechnology , medicine , minimum inhibitory concentration , antimicrobial , chemistry , biology , escherichia coli , biochemistry , gene

Multidrug-resistant Gram-negative bacteria, especially for extended-spectrum β-lactamases-producing and carbapenemase-producingEnterobacterales , are disseminating rapidly around the world. Treatment options for these infections are limited, which prompt the development of novel or combinational therapies to combat the infections caused by multidrug-resistant pathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research